Soleus Capital Management »

Equillium shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Equillium (EQ) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Equillium

Tip: Access up to 7 years of quarterly data

All positions including Equillium held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Equillium by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $288k 90k 3.20

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Celcuity (CELC)
Tg Therapeutics (TGTX)
Insulet Corporation (PODD)
Novocure Ord Shs (NVCR)
United Therapeutics Corporation (UTHR)
Inspire Med Sys (INSP)
Rigel Pharmaceuticals (RIGL)
Biosante Pharmaceuticals (ANIP)
Beta Bionics (BBNX)
Vericel (VCEL)
Praxis Precision Medicines I Com New (PRAX)
Geron Corporation (GERN)
Alkermes SHS (ALKS)
Erasca (ERAS)

View all positions for Soleus Capital Management

Top funds holding Equillium

Jupiter Topco
Henderson Group
Decheng Capital
Affinity Asset Advisors
ADAR1 Capital Management
Standard Life Aberdeen
Woodline Partners
RA Capital Management
Stempoint Capital
Vanguard Capital Management
Eversept Partners
Adage Capital Partners GP
Renaissance Technologies
Exome Asset Management
DG Capital Management

View all funds holding Equillium